An evaluation of forward and inverse radiotherapy planning using Helax-TMS (version 6.0) for lung cancer patients treated with rtog 93-11 dose-escalation protocol

Author： Underwood L.J.   Murray B.R.   Robinson D.M.   Field G.C.   Roa W.H.  

Publisher： Elsevier

ISSN： 0958-3947

Source： Medical Dosimetry, Vol.28, Iss.3, 2003-09, pp. : 167-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Daily-diary Evaluated Side Effects of Dose-escalation Radiotherapy of Prostate Cancer Using the Stereotactic Beamcath® Technique

By Fransson Per   Bergström Per   Löfroth Per-olov   Franzén Lars   Henriksson Roger   Widmark Anders  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 326-333

Informa Healthcare

Access to resources Recommend Favorite

Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: The RTOG RPA intra-classes analysis.

By Kepka Lucyna   Cieslak Ewa   Bujko Krzysztof   Fijuth Jacek   Wierzchowski Marek  

Acta Oncologica, Vol. 44, Iss. 4, 2005-06 ,pp. : 389-398

Informa Healthcare

Access to resources Recommend Favorite

Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)

By Massaccesi Mariangela   Ferro Marica   Cilla Savino   Balducci Mario   Deodato Francesco   Macchia Gabriella   Valentini Vincenzo   Morganti Alessio  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 784-791

Springer Publishing Company

Access to resources Recommend Favorite

Hazards of dose escalation in prostate cancer radiotherapy

By Kuban D.   Pollack A.   Huang E.   Levy L.   Dong L.   Starkschall G.   Rosen I.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1260-1268

Elsevier

Access to resources Recommend Favorite

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite